Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure Clinical research trials and Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure. Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure clinical trial. Participants frequently get the best healthcare available for their Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure



Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: This study is a 48-week study to evaluate the efficacy and safety of an investigational regimen combining FDA approved HIV drugs in antiretroviral-experienced subjects failing on their first highly active antiretroviral therapy regimen.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Currently on an initial HAART (highly active antiretroviral therapy) regimen of 3TC/ZDV or 3TC/d4T and a PI (protease inhibitor) -boosted or unboosted- or NNRTI (non-nucleoside reverse transcriptase inhibitor). - Plasma HIV - 1 RNA was <400 copies/ml on at least 2 documented occasions prior to viral rebound. - Have a plasma HIV - 1 RNA value >400 copies/ml and <10,000 copies/ml on 2 documented successive occasions (including screen) separated by at least 2 weeks. - A CD4+ lymphocyte count less than or equal to 100. Exclusion Criteria: - Have not taken Abacavir (Ziagen or Trizivir) or tenofovir (Viread) previously. - Have not had an AIDS defining illness within 30 days of screen. - Pregnant or breast-feeding. - Specified viral genotypes upon screening. - And other inclusion or exclusion criteria to be evaluated by the physician.
Total Enrollment: 

Location and Contact Information:

Study Site
Little Rock,  Arkansas,  72205
United States
 

Study Site
Altamonte Springs,  Florida,  32701
United States
 

Study Site
Dallas,  Texas,  75219
United States
 

Study Site
Chicago,  Illinois,  60637
United States
 

Study Site
Wenatchee,  Washington,  98801
United States
 

Study Site
San Rafael,  California,  94903
United States
 

Study Site
Des Moines,  Iowa,  50309
United States
 

Study Site
Milwaukee,  Wisconsin,  53226
United States
 

Study Site
Los Angeles,  California,  90015
United States
 

Study Site
Albany,  New York,  12208
United States
 

Study Site
Miami,  Florida,  33139
United States
 

Study Site
Union,  New Jersey,  07083
United States
 

Study Site
Chicago,  Illinois,  60657
United States
 

Study Site
Stratford,  Connecticut,  06614
United States
 

Study Site
New York City,  New York,  10468
United States
 

Study Site
Lafayette,  Indiana,  47904
United States
 

Study Site
Dallas,  Texas,  75246
United States
 

Study Site
Dallas,  Texas,  75248
United States
 

Study Site
Spokane,  Washington,  99204
United States
 

Study Site
Tallahassee,  Florida,  32303
United States
 

Study Site
Madison,  Wisconsin,  53792
United States
 

Study Site
Atlanta,  Georgia,  30309
United States
 

Study Site
Camden,  New Jersey,  08103
United States
 

Study Site
Houston,  Texas,  77004
United States
 

Study Site
Bronx,  New York,  10461
United States
 

Study Site
Phoenix,  Arizona,  85006
United States
 

Study Site
New Haven,  Connecticut,  06511
United States
 

Study Site
Berkeley,  California,  94705
United States
 

Study Site
Berkley,  Michigan,  48072
United States
 

Study Site
Valhalla,  New York,  10595
United States
 

Study Site
Philadelphia,  Pennsylvania,  19107
United States
 

Study Site
Miami,  Florida,  33136
United States
 

Study Site
New York City,  New York,  10014
United States
 

Study Site
Tampa,  Florida,  33614
United States
 

Study Site
Maywood,  Illinois,  60153
United States
 

Study Site
Evansville,  Indiana,  47710
United States
 

Study Site
Dallas,  Texas,  75205
United States
 

Study Site
St. Louis Park,  Minnesota,  55416
United States
 

Study Site
Seattle,  Washington,  98122
United States
 

Study Site
San Francisco,  California,  94114
United States
 

Study Site
Dallas,  Texas,  75208
United States
 

Study Site
Chicago,  Illinois,  60612
United States
 

Study Site
Akron,  Ohio,  44304
United States
 

Study Site
Ft. Lauderdale,  Florida,  33334
United States
 

Study Site
Safety Harbor,  Florida,  34695
United States
 

Study Site
Atlantis,  Florida,  33462
United States
 

Study Site
Decatur,  Georgia,  30033
United States
 

Study Site
Miami,  Florida,  33143
United States
 

Study Site
Minneapolis,  Minnesota,  55404
United States
 

Study Site
Tulsa,  Oklahoma,  74114
United States
 

Study Site
Los Angeles,  California,  90048
United States
 

Study Site
Washington D.C.,  District of Columbia,  20037
United States
 

Study Site
Jacksonville,  Florida,  32206
United States
 

Study Site
Atlanta,  Georgia,  30308
United States
 

Study Site
Newark,  New Jersey,  07102
United States
 

Study Site
Washington D.C.,  District of Columbia,  20009
United States
 

Study Site
Beverly Hills,  California,  90211
United States
 

Study Site
Dallas,  Texas,  75216
United States
 

Study Site
San Diego,  California,  92101
United States
 

Study Site
Miami,  Florida,  33139
United States
 

Study Site
Los Angeles,  California,  90069
United States
 

Study Site
St. Louis,  Missouri,  63108
United States
 


Additional Information:
Study ID Numbers:
  ESS 30005; 
Study Start Date: 
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00038506

Other Hiv Infections Studies:
1. A Study to Evaluate the Use of Memantine In Combination with Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

2. Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection

3. Treatment of Psoriasis Using Acitretin in HIV-Positive Patients

4. A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

5. A Study of a Combination of Four Drugs in Patients with Recent HIV Infection

Related Studies:

Other HIV Infections Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Modify your Search

  Other HIV Infections Clinical Trials
  Other Illinois Clinical Trials
  Other Chicago Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103